Drugs & TargetsFree China’s drug agency approves Opdivo for previously treated NSCLC June 22, 2018Vol.44 No.25
Drugs & TargetsFree Natera, Institut Jules Bordet to collaborate on neoadjuvant breast cancer assay June 22, 2018Vol.44 No.25
Drugs & Targets FDA approves Avastin in combination with chemotherapy for ovarian cancer June 15, 2018Vol.44 No.24
Drugs & Targets FDA approves Keytruda for previously treated patients with recurrent or metastatic cervical cancer whose tumors express PD-L1 June 15, 2018Vol.44 No.24
Drugs & Targets TESARO, Genentech to study Zejula with anti-PD-L1 agent, MEK inhibitor in ovarian cancer June 15, 2018Vol.44 No.24
Drugs & Targets FDA approves Venclexta with rituximab as a fixed duration treatment for CLL or SLL after one prior therapy June 15, 2018Vol.44 No.24
Drugs & Targets FDA, EMA accept application for talazoparib in metastatic breast cancer with inherited BRCA mutation June 15, 2018Vol.44 No.24
